Hahn AW - Search Results

1

Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and time.

Hahn AW, Stenehjem D, Nussenzveig R, Carroll E, Bailey E, Batten J, Maughan BL, Agarwal N. Hahn AW, et al. Cancer Treat Res Commun. 2019;19:100120. doi: 10.1016/j.ctarc.2019.100120. Epub 2019 Feb 6. Cancer Treat Res Commun. 2019. PMID: 30743187

2

Immunotherapy of advanced renal cell carcinoma: Current and future therapies.

Gill D, Hahn AW, Sonpavde G, Agarwal N. Gill D, et al. Among authors: hahn aw. Hum Vaccin Immunother. 2016 Dec;12(12):2997-3004. doi: 10.1080/21645515.2016.1212794. Epub 2016 Aug 5. Hum Vaccin Immunother. 2016. PMID: 27494417 Free PMC article. Review.

3

Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.

Gill DM, Stenehjem DD, Parikh K, Merriman J, Sendilnathan A, Agarwal AM, Hahn AW, Gupta S, Tantravahi SK, Samlowski WE, Agarwal N. Gill DM, et al. Among authors: hahn aw. Ecancermedicalscience. 2016 Sep 29;10:676. doi: 10.3332/ecancer.2016.676. eCollection 2016. Ecancermedicalscience. 2016. PMID: 27729941 Free PMC article.

4

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.

Kuzman JA, Stenehjem DD, Merriman J, Agarwal AM, Patel SB, Hahn AW, Alex A, Albertson D, Gill DM, Agarwal N. Kuzman JA, et al. Among authors: hahn aw. BMC Urol. 2017 Jan 5;17(1):1. doi: 10.1186/s12894-016-0192-0. BMC Urol. 2017. PMID: 28056941 Free PMC article.

5

Efficacy of Eplerenone in the Management of Mineralocorticoid Excess in Men With Metastatic Castration-resistant Prostate Cancer Treated With Abiraterone Without Prednisone.

Gill D, Gaston D, Bailey E, Hahn A, Gupta S, Batten J, Alex A, Boucher K, Stenehjem D, Agarwal N. Gill D, et al. Clin Genitourin Cancer. 2017 Aug;15(4):e599-e602. doi: 10.1016/j.clgc.2016.12.008. Epub 2017 Jan 5. Clin Genitourin Cancer. 2017. PMID: 28131750 Free PMC article.

6

Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer.

Agarwal N, Hahn AW, Gill DM, Farnham JM, Poole AI, Cannon-Albright L. Agarwal N, et al. Among authors: hahn aw. JAMA Oncol. 2017 Jun 1;3(6):856-857. doi: 10.1001/jamaoncol.2017.0147. JAMA Oncol. 2017. PMID: 28208175 Free PMC article.

7

Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications.

Hahn AW, Gill DM, Maughan B, Agarwal A, Arjyal L, Gupta S, Streeter J, Bailey E, Pal SK, Agarwal N. Hahn AW, et al. Oncotarget. 2017 May 16;8(20):33614-33620. doi: 10.18632/oncotarget.16833. Oncotarget. 2017. PMID: 28431395 Free PMC article.

8

The future of immune checkpoint cancer therapy after PD-1 and CTLA-4.

Hahn AW, Gill DM, Pal SK, Agarwal N. Hahn AW, et al. Immunotherapy. 2017 Jun;9(8):681-692. doi: 10.2217/imt-2017-0024. Immunotherapy. 2017. PMID: 28653573 Review.

9

Current Treatment Landscape of Advanced Papillary Renal Cancer.

Shuch B, Hahn AW, Agarwal N. Shuch B, et al. Among authors: hahn aw. J Clin Oncol. 2017 Sep 10;35(26):2981-2983. doi: 10.1200/JCO.2017.74.3328. Epub 2017 Jul 24. J Clin Oncol. 2017. PMID: 28737973 No abstract available.

10

Novel androgen axis systemic therapies for metastatic hormone-sensitive prostate cancer.

Hahn AW, Hale P, Rathi N, Agarwal N. Hahn AW, et al. Curr Opin Urol. 2017 Nov;27(6):559-565. doi: 10.1097/MOU.0000000000000443. Curr Opin Urol. 2017. PMID: 28816716 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters